Results of investment in associates

Philips Group
Results of investments in associates in millions of EUR
2012 - 2014
Company’s participation in income
Investment impairment and other charges
Dilution gain
Results of Investments in associates

This item is optimized for devices with a larger screen. You can still view this item in PDF format.
Download PDF

The results related to investments in associates improved from a loss of EUR 25 million in 2013 to a gain of EUR 62 million in 2014. 2014 included a EUR 32 million dilution gain related to Philips’ stake in Corindus Vascular Robotics, while 2013 included a provision for the net impact of expected payments related to the agreed transfer of the remaining 30% stake in the TP Vision joint venture.

The Company’s participation in income increased from EUR 5 million in 2013 to a gain of EUR 30 million in 2014. The gain in 2013 was mainly attributable to the results of Philips Medical Capital.

For further information, refer to note (5) Interests in entities.